Form 10 Explorer
10-K
Annual Report
VITASPRING BIOMEDICAL CO., LTD.

CIK: 1697884

File #: 333-216645

Period End: Jan 31, 2024

Fiscal Year: 2024

View on EDGAR
Balance Sheet
32 line items · 2 periods
XBRL
ItemJan 31, 2024Jan 31, 2023
BALANCE SHEETS
CURRENT ASSETS
Cash
1329,656
Accounts Receivable
0380,000
Other Non-Operating Current Assets
027,422
Other Current Assets
23,6140
Total current assets
23,627437,078
LONG-TERM ASSETS
Property, Plant and Equipment
24,06349,574
Operating Lease Right-of-Use Asset
89,652255,682
Other Non-Current Assets
023,614
Total long-term assets
113,715328,870
Total assets
137,342765,948
LIABILITIES AND STOCKHOLDERS' DEFICIT
CURRENT LIABILITIES
Accounts Payable
2,411,0002,411,000
Other Non-Operating Current Liabilities
339,00155,063
Taxes Payable
218,714218,714
Operating Lease Liability, Current
93,334169,647
Advances from related party
425,482214,682
Total current liabilities
3,487,5313,069,106
LONG-TERM LIABILITY
Operating Lease Liability, Non-Current
093,334
Total long-term liability
093,334
Total liabilities
3,487,5313,162,440
COMMITMENTS AND CONTINGENCIES
00
STOCKHOLDERS' DEFICIT
Total Stockholders' Equity
20,70320,703
Total Stockholders' Equity
1,135,689970,824
Total Stockholders' Equity
(4,506,581)(3,388,019)
Total stockholders' deficit
(3,350,189)(2,396,492)
Total liabilities and stockholders' deficit
137,342765,948